Personalized cancer treatments and better bone implants could grow from techniques demonstrated by graduate students Stephen W. Morton and Nisarg J. Shah, who are both working in chemical engineering professor Paula Hammond’s lab at MIT. Morton’s work focuses on developing drug-carrying nanoparticles to target hard-to-treat cancers — such as triple-negative breast cancer (TNBC) — while Shah develops coatings that promote better adhesion for bone implants. Continue reading about Morton and Shah’s research on MIT News. Pictured are Shah (left) and Morton (right); photo by Denis Paiste.
Morton and Shah’s research show progress toward better cancer treatment and bone replacement
July 30, 2014